NCT07077070

Brief Summary

This clinical study will evaluate a feature of the investigational Nexus Research System used for programming cochlear implants. Programming a cochlear implant-commonly referred to as MAP fitting-involves activating the device, allowing recipients to acclimatize to hearing sounds, and then fine-tuning the program based on the user's perception of loudness across different sounds. This process typically occurs over several visits and requires a clinician to collect data for the fine-tuning phase. The Nexus Research System includes an "Electrical Loudness Scaling" task, which participants can complete independently using a mobile application to collect the necessary data. Based on findings from previous studies, this feature has been revised to enable faster data collection. The current study will assess the performance of the updated feature. The study will involve experienced cochlear implant users. Participants will use the feature, undergo a series of hearing assessments-including evaluations of loudness perception-and provide feedback on the updated feature.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 22, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

October 21, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2025

Completed
Last Updated

January 8, 2026

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

June 20, 2025

Last Update Submit

January 7, 2026

Conditions

Keywords

Cochlear implantSensorineural hearing lossloudness scaling

Outcome Measures

Primary Outcomes (4)

  • Change in patient reported loudness rating scores for very soft sounds (loudness category 5) between Fast-ELS and Standard-ELS within one on-site session.

    To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session on-site.

    Day 0, Day 14

  • Change in patient reported loudness rating scores for loud sounds (loudness category 35) between Fast-ELS and Standard-ELS within one on-site session.

    To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session on-site.

    Day 0, Day 14

  • Change in patient reported loudness rating scores for very soft sounds (loudness category 5) between Fast-ELS and Standard-ELS within one at home session.

    To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session at home.

    Day 0 - Day 14

  • Change in patient reported loudness rating scores for loud sounds (loudness category 35) between Fast-ELS and Standard-ELS within one at home session.

    To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session at home.

    Day 0 - Day 14

Secondary Outcomes (8)

  • Correlation coefficient of very soft sounds (loudness category 5) obtained with Fast-ELS within one session on-site.

    Day 0, Day 14

  • Correlation coefficient of very soft sounds (loudness category 5) obtained with Fast-ELS within one session at home.

    Day 0 - Day 14

  • Correlation coefficient of loud sounds (loudness category 35) obtained with Fast-ELS within one session on-site.

    Day 0, Day 14

  • Correlation coefficient of loud sounds (loudness category 35) obtained with Fast-ELS within one session at home.

    Day 0 - Day 14

  • Correlation coefficient of very soft sounds (loudness category 5) obtained with Fast-ELS obtained during multiple sessions on-site.

    14 days

  • +3 more secondary outcomes

Study Arms (1)

Experimental: Participants receiving both Standard and Fast ELS task

EXPERIMENTAL
Device: Standard Electrical Categorical Loudness Scaling task (Standard-ELS)Device: Fast Electrical Categorical Loudness Scaling task (Fast-ELS)

Interventions

The Fast-ELS task employs an algorithm to estimate the lower and upper bounds of the loudness range using a limited number of samples. This range is then refined by collecting additional samples across various loudness categories for comprehensive coverage.

Experimental: Participants receiving both Standard and Fast ELS task

The Standard-ELS task is conducted using the Mobile Research Application within the Nexus Research system. It is completed in two phases: the first phase identifies the lower and upper bounds of the loudness range based on participant ratings, while the second phase collects data from stimulations delivered within the established range.

Experimental: Participants receiving both Standard and Fast ELS task

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least three months of experience with the cochlear implant.
  • Implanted with the CI600 series (CI612, CI622, CI632) or CI500 series (CI512, CI522, CI532) cochlear implant.
  • Able to be programmed with ACE (Advanced Combination Encoder), a fixed pulse width (PW) MAP with a maximum PW of 50 us per channel and with ≥ 18 enabled channels on the sound processor MAP.
  • Fluent speaker in the language used to conduct the study procedures, as determined by the investigator.
  • Willing and able to provide written informed consent and to comply with all requirements of the protocol.

You may not qualify if:

  • Participants programmed with an acoustic component in the tested ear.
  • Additional health factors, known to the investigator, that would prevent or restrict participation in the evaluations, including significant visual impairment and/or dexterity issues.
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the investigator.
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation.
  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless Cochlear sponsored and determined by investigator or Sponsor to not impact this investigation).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cochlear Denver Research Centre

Lone Tree, Colorado, 80124, United States

Location

Cochlear Technology Centre Belgium

Mechelen, Mechelen, B-2800, Belgium

Location

European Institute for Otorhinolaryngology (EIORL), ENT Department, Sint-Augustinus Antwerp

Antwerp, 2610, Belgium

Location

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Anke Plasmans

    Cochlear Limited

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2025

First Posted

July 22, 2025

Study Start

October 21, 2025

Primary Completion

December 24, 2025

Study Completion

December 24, 2025

Last Updated

January 8, 2026

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations